This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by FREY, E. A. Articles by KEBABIAN, J. W. Search for Related Content PubMed PubMed Citation Articles by FREY, E. A. Articles by KEBABIAN, J. W.

[³H]Spiroperidol Identifies a D-2 Dopamine Receptor Inhibiting Adenylate Cyclase Activity in the Intermediate Lobe of the Rat Pituitary Gland

Experimental Therapeutics Branch, National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20205

Address requests for reprints to: Dr. E. A. Frey, Building 10, Room 6D16, National Institutes of Health, Bethesda, Maryland 20205.

Abstract

[³H]Spiroperidol ([³H]SPIRO) binds with high affinity (K_d = 0.3 nM) to cell-free homogenates of the neurointermediate lobe of the rat pituitary gland. The neurointermediate lobe contains 19.2 fmol of specific binding sites, 86% of which occur in the intermediate lobe (IL). Compounds active upon the D-2 dopamine receptor in the IL compete with [³H] SPIRO for occupancy of the specific binding site. Guanosine 5'- triphosphate decreases the affinity of agonists, but not antagonists, for the specific binding site. For each drug tested, methods derived from competitive enzyme kinetics were used to calculate the apparent affinity constants of the drug for the binding site and for the receptor regulating adenylate cyclase activity. The pharmacological properties of the specific [³H]SPIRO binding site were compared to the pharmacological properties of the D- 2 dopamine receptor inhibiting adenylate cyclase activity in the IL. The similarity between the affinities determined from the binding and enzyme assays suggests that some or all of the specific [³H]SPIRO binding sites in the IL are D-2 dopamine receptors inhibiting adenylate cyclase activity.

Received October 21, 1981.

This article has been cited by other articles:

				S. Sedej, T. Rose, and M. Rupnik cAMP increases Ca2+-dependent exocytosis through both PKA and Epac2 in mouse melanotrophs from pituitary tissue slices J. Physiol., September 15, 2005; 567(3): 799 - 813. [Abstract] [Full Text] [PDF]

				H. D. Mansvelder, J. C. Lodder, M. S. Sons, and K. S. Kits Dopamine Modulates Exocytosis Independent of Ca2+ Entry in Melanotropic Cells J Neurophysiol, February 1, 2002; 87(2): 793 - 801. [Abstract] [Full Text] [PDF]